Synklino
Professor in Translational Pharmacology, University of Copenhagen. Co-founder of Synklino, Antag Therapeutics and Bainan Biotech.
This person is not in the org chart
This person is not in any offices
Synklino
1 followers
Synklino is a developer of a CMV-specific immunotoxin intended to eradicate the cytomegalovirus infection.